drugset / Trial / NCT05442437
Clinical Study of hUC-MSCs Treating Decompensated Liver Cirrhosis With HBV
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this study was to observe the safety ,tolerability ,Efficacy dose of human umbilical cord mesenchymal stem cells in patients of decompensated liver cirrhosis with HBV.
Timeline
- Start
- 2019-09-08
- Primary completion
- 2022-07-01
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 2.5e+07 cells | Intravenous |
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 5e+07 cells | Intravenous |
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 1e+08 cells | Intravenous |